News
HOFBF
0.330
NaN%
--
Hofseth BioCare Calls EGM to Approve Share Issue and B-Share Changes
TipRanks · 07/09 17:32
IFM Independent Fund Management to Hold 12.48% Voting Stake in Hofseth Biocare
TipRanks · 07/07 15:33
Hofseth BioCare Registers First Tranche of NOK 144.5 Million Share Issue
TipRanks · 07/03 12:02
Hofseth BioCare Clears All Agenda Items at 2026 AGM as Nutrition–Biotech Strategy Advances
TipRanks · 06/30 11:03
Hofseth BioCare Sees Strong Q2 Rebound, Raises Capital to Restore Full Production
TipRanks · 06/30 10:37
Insiders Back Hofseth BioCare’s NOK 144.5 Million Private Placement
TipRanks · 06/29 13:04
Hofseth BioCare reshapes ownership structure in NOK 144.5m private placement
TipRanks · 06/29 10:34
Hofseth BioCare Raises NOK 144.5 Million in Two-Tranche Private Placement
TipRanks · 06/28 22:02
Hofseth BioCare launches two-tranche private placement to raise up to NOK 175 million
TipRanks · 06/26 15:04
Hofseth BioCare Calls 2026 AGM as Upcycled Salmon Health Business Expands
TipRanks · 06/09 19:32
Hofseth BioCare Sets Out 2026 Financial Reporting Calendar
TipRanks · 05/28 17:32
Hofseth BioCare Seals Exclusive ProGo Supply Deal with U.S. Network-Marketing Partner
TipRanks · 05/22 01:13
Hofseth BioCare Sets 2026 Financial Reporting Schedule
TipRanks · 05/06 19:02
Hofseth BioCare Trial Shows OmeGo Outperforms Higher-Dose Omega-3 Rival
TipRanks · 04/14 09:35
Hofseth BioCare Publishes 2025 Reports and Awaits Completion of NOK 158m Share Issue
TipRanks · 03/27 19:47
Hofseth Biocare Completes Head-to-Head Omega-3 Trial, Setting Up a Key Catalyst for HOFBF
TipRanks · 02/23 16:30
Hofseth BioCare lifts Q4 revenues, boosts liquidity as nutrition and R&D gains offset losses
TipRanks · 02/13 12:09
IFM Consolidates 16.62% Voting Stake in Hofseth Biocare After Bonafide Fund Restructuring
TipRanks · 02/11 16:34
Hofseth BioCare ASA Cancels Subsequent Offering Amid Private Placement Delays
TipRanks · 12/15/2025 09:32
Hofseth BioCare Board Member Increases Stake
TipRanks · 11/21/2025 10:02
More
Webull provides a variety of real-time HOFBF stock news. You can receive the latest news about Hofseth Bio through multiple platforms. This information may help you make smarter investment decisions.
About HOFBF
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.